Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance

International Journal of Infectious Diseases

Volumn 14, Issue SUPPL. 4, 2010, Pages

  Stefani, Stefania ^a   Goglio, Antonio ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b Ospedale di Bergamo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DAPTOMYCIN; LINEZOLID; METICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM ISOLATION; CLINICAL LABORATORY; COMORBIDITY; HEART VALVE; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; PREVALENCE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; ITALY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; STAPHYLOCOCCAL INFECTIONS;

EID: 78149361140     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.05.009     Document Type: Article

References (25)

1. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10:505-20.
2. Graham P.L., Lin S.X., Larson E.L. A US population based survey of Staphylococcus aureus colonization. An Intern Med 2006, 144:318-325.
3. The European Antimicrobial Resistance Surveillance System (EARSS)-Annual Report 2007. Available at: (accessed December 29, 2009). http://www.rivm.nl/earss/.
4. Grundmann H., Hori S., Winter B., Tami A., Austin D.J. Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. J Infect Dis 2002, 185:481-488.
5. Grundmann H., Aires-de-Sousa M., Boyce J., Tiemermsma E. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public health threat. Lancet 2006, 368:874-885.
6. Loughman J.A., Fritz S.A., Storch G.A., Hunstand D.A. Virulence gene expression in human community-acquired Staphylococcus aureus infection. J Infect Dis 2009, 199:294-301.
7. Novick R. Staphylococcal pathogenesis and pathogenicity factors: genetic and regulation. Gram-positive pathogens 2006, ASM Press, Washington, DC, p. 496. 2nd ed. V.A. Fischetti, R.P. Novick, J.J. Ferretti, D.A. Portnoy, J.I. Rood (Eds.).
8. Cheung Al, Bayer A.S., Zhang G., Greshman H., Xiong Y.Q. Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol Med Microbiol 2004, 40:1-9.
9. Chambers H.F. Pathogenesis of staphylococcal infections: a manner of expression. J Infect Dis 2009, 199:291-293.
10. Campanile F., Bongiorno D., Borbone S., Stefani S. Hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Italy. Ann Clin Microbiol Antimicrob 2009, 8:22.
11. Stefani S, Monaco M, Campanile F, Cafiso V, Sanchini A, Marone P, et al. Characterization of Panton-Valentine leukocidin positive methicillin-resistant Staphylococcus aureus in Italy. European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, 2009; P1573.
12. Hidron A.J., Edwards J.E., Patel J., Horan T.C., Sievert D.M., Pollock D.A., et al. Antimicrobial resistant pathogens associated with healthcare associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infection Control Hosp Epidemiol 2008, 29:996-1011.
13. CDC National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999; 27:520-32.
14. Klevens R.M. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
15. Moellering R.C. The growing menace of community-acquired methicillin-resistant Staphylococcus aureus. Ann Intern Med 2006, 144:368-370.
16. Etienne J., Dimitrescu O. Panton-Valentine leucocidin associated Staphylococcus aureus infections. BMJ 2009, 339:408.
17. Courvalin P. Vancomycin resistance in Gram-positive cocci. Clin Infect Dis 2006, 42:S25-34.
18. Robinson D.A., Kearns A.M., Holmes A., Morrison D., Grundmann H., Edwards G., et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired methicillin-resistant clone. Lancet 2005, 365:1256-1258.
19. Jevons M.P., Coe A.W., Parker M.T. Methicillin resistance in staphylococci. Lancet 1963, 1:904-907.
20. Campanile F, Bongiorno D, Borbone S, Stefani S. Methicillin-resistant Staphylococcus aureus (MRSA) evolution: the multiple facets of an old pathogen. Eur Infect Dis 2010; 3: in press.
21. International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC). Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother 2009; 53:4961-7.
22. Sakoulas G., Moellering R.C. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis 2008, 46(Suppl 5):S360-S367.
23. Appelbaum P.C. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2007, 30:398-408.
24. Derenski S. Vancomycin heteroresistance and methicillin-resistant Staphylococcus aureus. J Infect Dis 2009, 199:605-609.
25. Maor Y., Hagin M., Belausov N., Keller N., Ben-David D., Rahav G. Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J Infect Dis 2009, 199:619-624.